Abstract
Minimal hepatic encephalopathy (MHE) is a neurocognitive disorder that can affect up to 80% of cirrhotic patients. Patients seem clinically unimpaired, but have subtle deficits and psychomotor abnormalities that can only be elicited by specialized tests. Used singly or in combination, varying tests can provide diagnostic information, including neuropsychological testing or neurophysiological testing. While there is no gold standard for the diagnosis, MHE remains an important entity for clinicians to recognize because of its negative impact on a patient’s health-related quality of life and association with driving impairment and vehicular accidents. The currently available tests are broadly divided into neuropsychological or neurophysiological. Prominent neuropsychological tests are the psychometric hepatic encephalopathy score, inhibitory control tests and repeatable battery for the assessment of neuropsychological status. Standard EEG and other variations thereof, critical flicker frequency as well as evoked potentials are the most studied neurophysiological tests. There is an immense variation in local norms for each test which makes standardization difficult. There is a clear need for the standardization of, and consensus on, employing these tools or developing a universally applicable tool in the evaluation and diagnosis of MHE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–21.
Hassanein T, Blei AT, Perry W, et al. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. Am J Gastroenterol. 2009;104(6):1392–400.
Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50(6):2014–21.
Cordoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011;54(5):1030–40.
Bajaj JS, Cordoba J, Mullen KD, et al. Review article: the design of clinical trials in hepatic encephalopathy—an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther. 2011;33(7):739–47.
Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther. 2010;31(5):537–47.
Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34(5):768–73.
Randolph C, Hilsabeck R, Kato A, et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29(5):629–35.
Dhiman RK, Kurmi R, Thumburu KK, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55(8):2381–90.
Garavan H, Ross TJ, Stein EA. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A. 1999;96(14):8301–6.
Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135(5):1591–600.e1591.
Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol. 2007;102(9):1903–9.
Bajaj JS, Saeian K, Schubert CM, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50(4):1175–83.
Amodio P, Ridola L, Schiff S, et al. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology. 2010;139(2):510–8.e511–2.
Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology. 2008;135(5):1582–90.
Montagnese S, Amodio P, Morgan MY. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis. 2004;19(3–4):281–312.
Amodio P, Pellegrini A, Ubiali E, et al. The EEG assessment of low-grade hepatic encephalopathy: comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clin Neurophysiol. 2006;117(10): 2243–51.
Montagnese S, Jackson C, Morgan MY. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. J Hepatol. 2007;46(3):447–58.
Kullmann F, Hollerbach S, Holstege A, Scholmerich J. Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol. 1995;22(1):101–10.
Zeneroli ML, Pinelli G, Gollini G, et al. Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy. Gut. 1984;25(3):291–9.
Blauenfeldt RA, Olesen SS, Hansen JB, Graversen C, Drewes AM. Abnormal brain processing in hepatic encephalopathy: evidence of cerebral reorganization? Eur J Gastroenterol Hepatol. 2010;22(11):1323–30.
Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002;35(2):357–66.
Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47(1):67–73.
Romero-Gomez M, Cordoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45(4):879–85.
Montagnese S, Gordon HM, Jackson C, et al. Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment. Hepatology. 2005;42(4):772–81.
Company L, Zapater P, Perez-Mateo M, Jover R. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2010;22(5):519–25.
Jover R, Company L, Gutierrez A, et al. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Am J Gastroenterol. 2003;98(7):1599–604.
Jimenez B, Montoliu C, MacIntyre DA, et al. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance. J Proteome Res. 2010;9(10):5180–7.
Cordoba J, Sanpedro F, Alonso J, Rovira A. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis. 2002;17(4):415–29.
Rovira A, Alonso J, Cordoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol. 2008;29(9):1612–21.
Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology. 2007;45(3):833–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Montgomery, J.Y., Bajaj, J.S. (2012). Diagnosis of Minimal Hepatic Encephalopathy. In: Mullen, K., Prakash, R. (eds) Hepatic Encephalopathy. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-836-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-61779-836-8_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-835-1
Online ISBN: 978-1-61779-836-8
eBook Packages: MedicineMedicine (R0)